Blood-based biomarker panels for preclinical detection

Blood Based Biomarker Panels For Preclinical Detection enters the Adult Cognitive Disease corpus through the work of Gerhard Multhaup (submission 130), and is indexed here as one of the concepts that submission puts to work.

The argument it belongs to

Gerhard Multhaup's submission is summarised in this corpus as:

AD requires a probabilistic systems-based approach rather than a deterministic single-mechanism explanation. The proposal introduces three paradigm shifts: impaired amyloid clearance (not just deposition) via BACE1 dual activity, nuclear effects of Abeta42 and tau on gene expression and transport, and blood-based deep proteomics biomarker panels for earlier diagnosis.

Where it sits

The submission scores against the framework's convergence nodes as: transcriptional / epigenetic 6 · compensatory paradigm 4 · endosomal nexus 3 · cytoskeletal collapse 2 · neuroimmune interface 2 · ApoE4 hub 2.

Its declared subject matter: amyloid clearance, systems biology, deep proteomics, biomarkers, nucleocytoplasmic transport, BACE1, precision medicine, blood-based diagnostics.

Named by the same submission

3 other concepts enter the corpus through the same paper, so they cover adjacent ground: Amyloid clearance as important as deposition · Nuclear pathology as early AD mechanism · Probabilistic multi-cause disease etiology.

Assembled from the corpus rather than written: the summary is quoted from the submission that named it; the node scores are read from its dossier. It has not yet been expanded into an article.